Why MD Cybersecurity is so important
Why MD Cybersecurity is so important by Danilo Maruccia, Executive Consultant & […]
Category: News
CMDh raising risk awareness on Nitrosamine Impurities
On September 26th, 2019 the CMDh published the notice “Information on nitrosamines for marketing authorisation holders” asking to all Marketing Authorization Holders (MAHs) of human medicinal products containing chemically synthesised active pharmaceutical ingredients to evaluate the risk of the presence of nitrosamine impurities in their products. This includes generics and over-the counter (OTC) products.
OsservatorioPMI 2019. PQE Group receives the “Excellent Company” award
PQE Group has been awarded for the 2nd year in a row, […]
“Ciao Pino!” PQE funds ALS Research in memory of deceased client employee.
In memory of beloved Giuseppe “Pino” Santoni, member of Pfizer company, his […]
Vaping suspected for health consequences, needs regulation
National Heart, Lung and Blood Insititute (MD) revealed potential blood and respiratory consequences, Vaping reportedly involved in death and illness cases in Illinois; suspected long-term effects.
‘Flying Dreams’: PQE presents Nepal initiative documentary
PQE Group presented the documentary ‘Flying Dreams’ on the occasion of the “Festival of Culture – Summer Nights 2019” on the experience lived by the employees in a school in Kathmandu.
PQE’s project on MS is a reality
Project co-financed under Tuscany POR FESR 2014 – 2020 – Measure 1.1.5
PQE starring at “Meet the Champions” event by Italy Post & “L’Economia”
PQE Group was the special guest for “Meet the Champions” event. PQE […]
PQE Group for Social Responsibility: volunteering experience in a school in Kathmandu, Nepal.
Last December, the PQE Group communication department sent an email to
the 600 employees with an invitation to participate in a contest: the prize consisted of a 10-day trip to Nepal,
where in addition to trekking, resources will have the possibility to be volunteer for a week at the Moonlight
School in Kathmandu.
FDA temporarily raising tolerance on impurities due to market shortage
FDA has issued setting temporary rules on a probable cancer-causing impurity formerly […]